Ombit Pharma Private Limited
About Ombit Pharma Private Limited
Data last updated:
Ombit Pharma Private Limited is a private limited company based in Chandlodiya, Gujarat, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 02 February 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2022PTC129046. Its GSTIN is 24AAICN0588K1Z5 (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors including Rushang Govindbhai Patel and Hetalbahen Kamleshkumar Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 702 – Shlok Infinity Opp. Vishwakarma Mandir Near Gota Railway Bridge, Chandlodiya, Gujarat, India – 382481.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.9 Cr, a growth of 66% compared to the previous year. For the same year it recorded a net profit of ₹1.28 Lakh (net margin 0.2%) and EBITDA of ₹11.47 Lakh (EBITDA margin 1.7%).
The company has about 72 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ombit Pharma Private Limited's registered office is in Chandlodiya, Gujarat. Its e-mail address is in the company report.
- Email
- Registered Address702 – Shlok Infinity Opp. Vishwakarma Mandir Near Gota Railway Bridge, Chandlodiya, Gujarat, India – 382481
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Ombit Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ombit Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Ombit Pharma Private Limited, buy the company report.
Financials of Ombit Pharma Private Limited
FY 2025 filings availableOmbit Pharma Private Limited reported revenue of ₹6.9 Cr (up 66% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 66% in the latest year. EBITDA rose 148% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹11.47 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.28 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.7% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ombit Pharma Private Limited, buy the company report.
Board of directors of Ombit Pharma Private Limited
Ombit Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rushang Govindbhai Patel | Director | 02 Feb 2022 | 4 Years 8 Months | Current |
| Hetalbahen Kamleshkumar Patel Also directs: Novumgen Private Limited | Director | 05 Sep 2024 | 2 Years 1 Months | Current |
| Kamleshkumar Babulal Patel Also directs: Novumgen Private Limited, Topia Pharma Intelligence Private Limited, Topia Medtech Private Limited and 1 more | Director | 05 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Ombit Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jehangir Clinical Developement Centre Private Limited | ₹6.95 Cr (FY 2024) | 0.0% | Pune, Maharashtra, India | |||
| Mediforce Research Private Limited | ₹6.92 Cr (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Ombit Pharma Private Limitedthis company | ₹6.9 Cr (FY 2024) | ₹1.28 Lakh | 0.2% | 66.0% | 72 | Chandlodiya, Gujarat, India |
| Adept Pharma and Bioscience Excellence Private Limited | ₹6.77 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| Ignite Life Science Foundation | ₹6.54 Cr (FY 2025) | 10.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Ombit Pharma Private Limited, buy the company report.
Auditor
Ombit Pharma Private Limited is audited by RAHUL KAUSHIK AND CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAHUL KAUSHIK AND CO. | FY 2023 | 138132W |
Legal cases
No court or tribunal cases involving Ombit Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ombit Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ombit Pharma Private Limited has a workforce of 72 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
GST
Ombit Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICN0588K1Z5 | Gujarat | Active | 10 May 2022 |
To see the full GST registrations and return filing status of Ombit Pharma Private Limited, buy the company report.
Recent activity
Ombit Pharma Private Limited has 6 board changes on record since 2022: 3 appointments and 3 cessations. The latest: Hetalbahen Kamleshkumar Patel ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Ombit Pharma is an active private limited company based in Chandlodiya, Gujarat, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 02 February 2022 (4+ years old) and is registered under CIN U24290GJ2022PTC129046.
Ombit Pharma has 3 current directors:
- Rushang Govindbhai Patel - Director
- Hetalbahen Kamleshkumar Patel - Director
- Kamleshkumar Babulal Patel - Director
The latest financial statements of Ombit Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Ombit Pharma is 24AAICN0588K1Z5, registered in Gujarat.
The CIN (Corporate Identification Number) of Ombit Pharma is U24290GJ2022PTC129046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ombit Pharma was incorporated on 02 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Ombit Pharma by revenue are Jehangir Clinical Developement Centre Private Limited, Mediforce Research Private Limited, Adept Pharma and Bioscience Excellence Private Limited, Ignite Life Science Foundation, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Hetalbahen Kamleshkumar Patel ceased to be Additional Director on 29 Sep 2024. Kamleshkumar Babulal Patel ceased to be Additional Director on 29 Sep 2024. Govindbhai Babubhai Patel ceased to be Director on 06 Sep 2024. Ombit Pharma has 6 board changes on record in total.
The registered office of Ombit Pharma is at 702 – Shlok Infinity Opp. Vishwakarma Mandir Near Gota Railway Bridge, Chandlodiya, Gujarat, India – 382481.
Ombit Pharma operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of Ombit Pharma is compliant as of 18 August 2026. The company is actively filing with the Registrar of Companies.